Unexpected Protein Structure May Lead to New Cancer Treatments
University of Iowa researchers have uncovered an unexpected double-ring structure in the DNA repair protein RAD52, revealing new insights that could guide the development of next-generation cancer drugs.
Featured Articles.
PHARMA
World-First Preventative Lung Cancer Vaccine Enters Clinical Trial
Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease
Tinlarebant becomes the first therapy to show clinical benefit in a pivotal global trial, reducing retinal lesion growth by 36% and paving the way for a planned FDA filing in 2026.
World-First Preventative Lung Cancer Vaccine Enters Clinical Trial
A groundbreaking clinical trial set to begin in summer 2026 will test LungVax, the world’s first vaccine designed to prevent lung cancer in people at high risk, a major milestone in cancer prevention research.